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Background & aims: Children with intestinal failure (IF) receive parental nutrition to ensure adequate
growth and development. The aim of this study was to assess micronutrient status in paediatric IF pa-
tients receiving home parenteral nutrition (HPN) in comparison to a group of healthy children.
Methods: An observational cross-sectional study was performed at Oslo University Hospital and at the
Department of Nutrition, University of Oslo from January to September 2017. All children with IF, aged
two to 18 years, were invited to participate. A reference group of healthy children was recruited through
social media advertisement. Dietary intake was assessed by a four-day food record, and enteral and
parenteral provision was recorded. Blood samples were analysed for vitamins, minerals and haematology
to assess iron status. Two spot urine samples from each subject were analysed for iodine concentration
(UIC) and creatinine.
Results: Nineteen children with IF and 50 healthy children were included. The mean age of the partic-
ipants was 10.0 years. IF-patients received a median of 76% of their estimated energy requirements from
parenteral nutrition (PN). Recommended intake (RI) for iodine from the diet was reached by 16% of IF
patients and 28% of healthy children. In the IF group there was a significant positive correlation between
UIC and the percentage of iodine intake from oral diet and enteral nutrition support (r ¼ 0.57, p ¼ 0.03).
Although the IF patients had a median parenteral iodine supply of more than twice the ESPGHAN
recommendation, the median UIC was 89 mg/L indicating insufficient iodine status. This may suggest that
the ESPGHAN recommendation for iodine in paediatric parenteral nutrition is too low. The healthy
children had sufficient iodine status according to the median UIC (133 mg/L). IF patients had significantly
lower total provision of iron compared to the healthy children, 4,9 vs 8,4 mg/day (p ¼ 0.01) with 21% of IF
patients and 28% of healthy children reaching RI for iron. The prevalence of anaemia was higher in IF
patients than in the healthy children (40 vs.10%, p ¼ 0.016).
Conclusion: The study indicates an insufficient iodine and iron status among paediatric IF patients. Iodine
status was associated with enteral provision and patients had insufficient status even if they received the
ESPGHAN recommendation of iodine.
Trial identification number: Clinical Trials AEV2017/1. 2016/391/REK sør-øst B.
© 2020 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).nts; ESPGHAN, European Society of Paediatric Gastroenterology Hepatology and Nutrition; HPN, Home parenteral
IPO, Paediatric intestinal pseudo obstruction; PN, Parenteral nutrition; RI, Recommended intake; TPN, Total parenteral
Medicine, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Pb 4950 Nydalen, 0424, Oslo,
en).
ier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Intestinal failure (IF) is defined as a critical reduction of func-
tional gut mass below the minimum needed for the absorption of
nutrients and fluids necessary to maintain health and growth [1,2].
IF can result from anatomical resection of the gut length resulting in
short bowel syndrome, neuromuscular diseases causing dysmo-
tility of the gastro-intestinal (GI) tract, or diseases of the intestinal
epithelium causing chronic malabsorption [3e5]. The insufficient
digestion and absorption in these patients make parenteral nutri-
tion (PN) vital [6,7]. Patients with IF may be eligible for treatment
with home parenteral nutrition (HPN) [8], which enables the pa-
tient to receive this nutritional treatment at home when hospital-
ization is no longer required. HPN is widely recognized to improve
the quality of life of both children and families involved [9].
Even so, growth failure and negative energy- and protein bal-
ances have previously been reported among paediatric HPN pa-
tients [10,11]. In addition, it is essential to prevent micronutrient
imbalances in long-term HPN [12]. Children are especially vulner-
able to micronutrient deficiencies due to growth and development.
Therefore, monitoring vitamin and mineral status is recommended
in these patients [13,14]. Neelis et al. found low blood values of
vitamin A in 90%, zinc in 87%, and iron in 76% of IF children on HPN
[15]. Other studies have indicated that supplying iodine and iron
may be challenging [16e20]. Retrospective reports on the outcome
of long term HPN have mostly aimed at describing survival, growth
pattern, macronutrient status and time to weaning off HPN
[9,10,14]. Several studies have focused on the micronutrient status
during and after weaning of PN [7,15,21,22] Only a few studies have
focused on the micronutrient status in children with chronic IF
dependent on long-term PN, and data onmicronutrient provision is
often incomplete or lacking [22,23]. The aim of the present study
was to assess micronutrient provision and status in a group of
paediatric IF patients on home parenteral nutrition in comparison
to a group of healthy children.2. Methods
2.1. Subjects
An observational cross-sectional study was conducted on pae-
diatric patients treated with HPN due to IF and a group of healthy
children from March to September 2017. The IF patients were
recruited at routine follow-up examination by the Paediatric In-
testinal Failure Team at Oslo University Hospital. The inclusion
criteria were age between two and 18 years and dependent on HPN
for more than 6 months. A reference group of healthy children in
the same age group was recruited by social media advertisement.
The inclusion criteria were residence in the Oslo region, age 2e18
years, and a normal diet. Clinical data on primary diagnosis of IF,
time of commencing and length of HPN treatment were obtained
from medical records of the IF patients. Demographic data, data on
parenteral education and living arrangements and gastrointestinalTable 1
Classification of anaemia and cut-off values for iron deficiency according to WHO [29,30
Age Haemoglobin g/dl
Mild Anaemia M
6 monthse4 yrs 10,0e10,9 7,
5e11 years 11,0e11,4 8,
12e14 years 11,0e11,9 8,
>15 years Girls 11,0e11,9 8,
Boys 11,0e12,9 8,symptoms were obtained from a questionnaire, completed by pa-
tients and healthy children if over 16 years and by parents if under
16, in order to compare IF patients and healthy children.
2.2. Anthropometrics
Anthropometric measurements of weight and height were
registered at routine follow-up examinations at the HPN-clinic at
Oslo University Hospital for the IF children. For the healthy chil-
dren, the same measurements were obtained at a visit to the
Clinical Nutrition Research Centre at the University of Oslo. The
anthropometric measurements were analysed by calculating stan-
dard deviation scores (SDS) for weight for age (weight SDS), height
for age (height SDS) and BMI for age (BMI SDS), based on the
Norwegian reference population [24].
2.3. Nutrient intake
A 4-day food record was kept for all the participants, using
house hold measures and booklet of portion sizes [25]. Information
on the amount and types of enteral and parenteral support was
collected for the IF children. An internet based dietary analysis
program (DietistPro) was used to calculated dietary intake of en-
ergy, protein, fat, carbohydrate, electrolytes, minerals, trace ele-
ments and vitamins based on the mean intake of the four days from
diet and enteral support (EN), parenteral nutrition and total pro-
vision of nutrients for the IF patients and dietary intake for the
healthy children. Prescriptions for the parenteral nutrition solu-
tions were provided by Hospital Pharmacies and were calculated
and added to the diet analysis by a dietitian. Data on the initiation
and duration of parenteral nutrition were provided by parents and
medical records. Parenteral nutrition was supplemented with
multivitamin and trace element parenteral products. The Nordic
Nutrition Recommendations [26] were used as reference values for
recommended intake (RI) from diet and EN. The proportion (%) of
participants that reached the RI for different nutrients was deter-
mined for both groups. Nutrient reference values for parenteral
nutrition were taken from the ESPGHAN guidelines on paediatric
parenteral nutrition [27,28] and the proportion of IF patients
reaching the recommendations assessed. Minerals and trace
element provision from parenteral nutritionwere calculated per kg
body weight in order to be able to compare the values to the
ESPGHAN recommendations.
2.4. Blood samples
The blood samples of the IF patients were analysed for haema-
tology (haemoglobin, ferritin, iron, total iron binding capacity
(TIBC), MCV, MCH, transferrin receptor), C-reactive protein, albu-
min, vitamins A and E, folate, B12, zinc, selenium, copper, carnitine,
liver status (ASAT, ALAT, gamma-GT, bilirubin), lipid status
(cholesterol, HDL, LDL) and thyroid function (thyroid stimulating
hormone (THS), free thyroxine (FT4)). Only a selection of these].
Ferritin ug/L







Baseline characteristics, Gastrointestinal symptoms, Aetiology of Intestinal Failure and Nutritional Treatment.
Intestinal failure (n ¼ 19) Healthy (n ¼ 50) p-value
General characteristics
Gender, Boys % 68% 36% 0.02
Age in years, mean (SD) 10.1 (3.51) 10.0 (3.59) 0.93
Height SDS, mean (SD) 1.52 (1.69) 0.65 (1.18) 0.001
Weight SDS, mean (SD) 1.02 (1.57) 0. 60 (0,93) 0.009
BMI SDS, mean (SD) 0.20 (1.04) 0.02 (1.07) 0.51
Parents living together 79% 84% 0.62
Gastro intestinal symptoms Daily/weekly
Gastro intestinal symptoms 95% 16% <0.001
Loose stools 68% 2% <0.001
Gastro Intestinal pain 63% 4% <0.001
Constipation 26% 2% 0.005
Regurgitation 16% 4% 0.08
Vomiting 15% 0% 0.02
Gas 90% 4% <0.001
Aetiology
PIPO 58%
Short Bowel Syndrome 26%
Chronic Malabsorption 16%
Nutritional treatment
Median age at PN initiation, years (minemax) 3 (0e10)
Median time on PN, years (minemax) 4.4 (0.8e16.4)
Median PN days per week (minemax) 7 (4e7)
Median volume PN, ml (minemax) 1268 (297e2030)
Median time per PN infusion, hours (minemax) 12 (9e15)
EER covered by PN 76%
TPN 21%
PN þ Enteral nutrition support 16%
PN þ Diet 37%
PN þ Enteral nutrition support þ Diet 26%
SDS ¼ Standard deviation Scores, PIPO ¼ Paediatric Intestinal Pseudo Obstruction, PN ¼ Parenteral nutrition, EER ¼ Estimated energy requirements, TPN ¼ total parenteral
nutrition.
P-value ¼ differences between Intestinal failure and Healthy children
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reactive protein, albumin, folate and B12). Anaemia was deter-
mined using the WHO's reference value for haemoglobin according
to age and sex [29] and iron deficiency was determined using
reference values for ferritin [30] (Table 1).2.5. Urine samples
Two spot urine samples were collected during the 4-day diet
recording for the analysis of iodine and creatinine. Iodine samples
were analysed at the Norwegian University of Life Sciences. Suffi-
cient iodine status according to urinary iodine content (UIC) was set
as 100 ug/L in accordance with the WHO's cut off value [31]. UrineTable 3a
Median vitamin provision from enteral and parenteral nutrition in intestinal failure pati
Intestinal Failure (n ¼ 19)
Total Enteral PN
Median (25e75 p) Median (25e75 p) Median (25e
B1 mg 2,6 (2,2e3,0) 0,6 (0,1-1) 2,5 (1,8
B2 mg 3,8 (3,2e4,2) 0,8 (0,1-1) 3,5 (2,6
B6 mg 4,2 (3,6e4,5) 0,5 (0,1-1,4) 3,9 (2,9
B12 ug 5,6 (4,9e7,4) 1,9 (0,4e3,0) 4,9 (3,7
Folate ug 416 (393e528) 83 (16e182) 393 (300
Niacin mg 42 (36e45) 5,7 (0e12,5) 39,3 (29,
Vit A ug 1078 (690e1800) 266 (72e600) 690 (525
Vit C mg 109 (100e136) 15 (1e86) 98 (74e
Vit E mg 13,3 (7,2e17,8) 4,5 (0,3e10) 6,4 (4,7
IF ¼ Intestinal Failure, PN ¼ Parenteral Nutrition, Reference RI ¼ Recommended daily
Reference PN ¼ ESPGHAN recommendations.
a P values Total: median Total (Enteralþ PN) provision in the IF group compared to inta
enteral nutrition support) in the IF group compared to dietary intake in the healthy chilcreatinine was analysed at the laboratory of Oslo University Hos-
pital. The estimated 24-h urinary iodine content (Est24hrUIC) was
calculated to adjust for hydration status using the equation sug-
gested by Montenegro-Bethancourt et al. [32]. Est24hrUIE were
then assessed in relation to the recommended daily iodine intake
adjusted for 15% non-renal iodine loss.2.6. Statistics
Statistical analyses were performed using IBM SPSS Statistics for
Windows version 25. Categorical variables are presented as
numbers (n) and frequencies (%). Continuous variables are tested
for normality. Normally distributed data is presented asmeanswithents and diet in healthy children (25th-75th percentile).
Healthy (n ¼ 50)
Dietary intake Reference P valuesa
75 p) Median (25e75 p) RI PN Total Enteral
e2,5) 1,3 (1,1-1,5) 0,6e1,4 1,2 <0.001 <0.001
e3,6) 1,4 (1,1-1,7) 0,7e1,7 1,4 <0.001 0.001
e4,0) 1,4 (1,1-1,8) 0,7e1,6 1 <0.001 0.001
e5,0) 4,5 (3,3e6,5) 0,8e2,0 1 0.014 <0.001
e400) 187 (153e228) 80e300 140 <0.001 <0.001
4e40) 14,4 (11,4e18,6) 9e19 17 <0.001 <0.001
e1035) 485 (371e761) 350e900 150 <0.001 0.015
100) 65 (44e81) 30e75 80 <0.001 0.004
e9,6) 10,5 (7,9e13,6) 5e10 11 0.1 0.003
intake (Diet and Enteral nutrition support, Nordic nutritional recommendations),
ke from diet in healthy children. P values Enteral: Median Enteral provision (diet and
dren.
Table 3b
Median total mineral and trace element provision from enteral and parenteral nutrition in intestinal failure patients and diet in healthy children (25th-75th percentile).
Intestianl Failure (n ¼ 19) Healthy (n ¼ 50)
Total Enteral PN Diet Reference P-valuea
Median (25e75 p) Median (25e75 p) Median (25e75 p) Median (25e75 p) RI PN Total Enteral
Cu mg 0,6 (0,3e1,3) 0,4 (0e1,1) 0,3 (0,2e0,3) 0,9 (0,8e1,1) 0,4e0,9 0.06 0.005
Cu ug/kg 8,8 (5,6e11,4) 20
Iodine ug 116 (85e159) 40 (3,6e80,5) 94 (60e111) 88 (72e142) 90-150b 0.9 <0.001
Iodine ug/kg 2,7 (0,3-3,4) 1
Iron mg 4,9 (1,7e10,1) 4,3 (0,6e9,3) 0,8 (0,5e0,9) 8,4 (7,0e10,3) 8-15c 0.01 0.003
Iron ug/kg 20 (0e300) 50e100
K mg 2520 (1867e3600) 928 (27e1625) 1602 (1002e2200) 2520 (2073e3058) 1800e3500 0.9 <0.001
K mmol/kg 1,5 (0,7e1,8) 1e3
Mg mg 173 (94e228) 103 (15e148) 65 (48e96) 263 (230e338) 120e350 <0.001 <0.001
Mg mmol/kg 0,1 (0,04e0,17) 0,1
Na mg 2189 (1481e3105) 601 (47e1052) 1564 (927e2189) 2527 (1947e2999) 0.4 <0.001
Na mmol/kg 2,5 (1,0e2,7) 1e3
Se ug 71 (58e108) 18,6 (2,6e48) 57,2 (36,5e65,5) 37 (30e50) 25e60 <0.001 0,007
Se ug/kg 1,7 (1,4e2,1) 2e3
Zn mg 6,5 (4,5e11,2) 4 (0,6e7,5) 3,6 (2,3e4,3) 9,7 (7,3e11,9) 6e12 0.017 <0.001
Zn ug/kg 100 (90e130) 50
IF¼Intestinal Failure, Enteral ¼ Diet and Enteral nutrition support, PN ¼ Parenteral Nutrition, Reference RI¼ Recommended intake (Diet and Enteral nutrition support, Nordic
nutritional recommendations), Reference PN ¼ ESPGHAN recommendations Mg ¼ magnesium, Na ¼ sodium, K ¼ potassium, Zn ¼ zinc, Se ¼ selenium, Cu ¼ copper.
a P values Total: median Total (Enteral þ PN) provision in the IF group compared to intake from diet for in healthy children. P values Enteral: Median Enteral provision (diet
and enteral nutrition support) in the IF group compared to dietary intake in the healthy children.
b Lowest at 2e5 yrs, gradually increasing until age 17.
c highest value for girls 14e17 yrs.
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sented as medians with range (minimumemaximum). The two-
sided significance level was set at five % for all statistical analysis.
Data on general characteristic and gastrointestinal symptoms are
expressed as frequencies and the IF patients and healthy children
are compared using the Chi-square test. Anthropometric data are
compared using Independent Sample T-test. Data on provision of
nutrients are presented as median with 25th and 75th percentile.
Differences in total provision and enteral provision of a micro-
nutrient between the two groups are tested separately, using the
Mann-Whitney U test. Micronutrient status and haematology are
presented as medians with range and the two groups are compared
usingMann-Whitney U test. Numbers of subjects with values above
or below the normal range are presented as frequencies (%).
Spearman's correlation coefficient is used to explore correlations
between iodine status (UIC) and nutritional parameters, as well as
anaemia and nutritional parameters. Differences in the prevalence
of anaemia in the two groups is tested using Fisher's Exact test.
2.7. Ethics
Informed consent was collected from both parents for children
under 16 years and from parents and participants aged 16e18
years. Approval for the study was obtained from the Regional
Committee for Medical and Health Research Ethics in Norway (REC
nr. 2016/391), the Head of the Department and the Research
committee, Oslo University Hospital. The study was registered in
Clinical Trials (AEV2017/1), and the Ethical standards of the
Declaration of Helsinki were followed.
3. Results
The study included all 19 children with IF between 2 and 18
years old who were treated with HPN and seen at Oslo University
Hospital between January and September 2017. Another 50
healthy children were recruited as a reference group. The baseline
characteristics and clinical data are presented in Table 2. Themean
age was 10.1 years in the IF group and 10.0 years in the healthygroup, and there were significantly more boys in the IF group. The
primary diagnosis of IF included paediatric intestinal pseudo
obstruction (PIPO) (58%), short bowel syndrome (26%) and
chronic malabsorption (16%). The IF patients were significantly
shorter (length SDS) and lighter (weight SDS) than the healthy
group, but there was no difference in BMI SDS. Parenteral edu-
cation level (results not shown) and living arrangement did not
differ between the two groups. The IF patients had significantly
more GI symptoms than the healthy children and gas production
was the most frequently reported symptom (90% of the IF
patients).
The median age of HPN initiation was three years, with 47%
having commenced HPN during their first year of life. The median
treatment duration was 4.4 years. The median number of days of
infusion per week was seven with a median duration of 12 h per
infusion. As presented in Table 2, four patients had 100% PN, three
had PN in combination with enteral nutrition support (EN), seven
were treated with PN together with oral diet and five with PN in
combination with both EN and diet. PN was the main provider of
nutrition with EN and/or diet covering a mean of 2-4% of estimated
energy requirements.
We found no clear correlation between the underlying cause of
IF and the type of nutritional support, except for TPN which was
provided to PIPO patients only. There was no significant difference
in median total energy intake (1834 vs 1913 kcal) between the IF
patients and the healthy group.
PN was individually tailored for most patients, but two IF pa-
tients received standard all-in-one bags (Fresenius Standard
15e40 kg, Fresenius Kabi Norway). All patients were provided with
a water-soluble multivitamin and a trace element parenteral
product. All but one patient also received a fat-solublemultivitamin
parenteral supplement.
3.1. Micronutrient intake
The data on micronutrient provision are shown in Table 3a and
b. In the IF group, there was a significantly higher total provision of
vitamin A, all the water-soluble vitamins (B1, B2, niacin, B6. B12,
Fig. 1. Frequency of IF patients reaching the enteral (RI) and parenteral recommendation for individual micronutrients. Diet and Enteral ¼ Recommended intake (RI) for Diet
and enteral nutrition support.Parenteral ¼ ESPGHAN guidelines ¼ Recommended provision in Parenteral nutrition.
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a significantly lower provision of iron, magnesium, and zinc than
the reference group. No difference was found in total provision of
vitamin E, copper, iodine, potassium or sodium between the two
groups.
As shown in Fig. 1, 58% of the IF group met the dietary recom-
mendation (RI) for B12 through diet and enteral nutrition support,
but the RI was reached by only 42% for vitamin A and E, 37% for
vitamin C; 32% for B1, B2 and selenium, 26% for niacin,; and less
than 22% for zinc and magnesium. The RI for iodine and iron was
reached by 16 and 21%, respectively. IF patients were providedmost
of their iodine from PN (63% of total provision) and the main
contributor of iron for the majority of IF children were diet and/or
enteral nutrition support, however the provision was less than 50%
of RI.
The ESPGHAN guidelines [27,28] for micronutrient provision in
PN were met by 95% of the IF group in the case of B-vitamins, zinc
and vitamin A, by 63% for vitamin C, 42% for magnesium, 32% for
selenium, and 21% for vitamin E. Median provision of iodine was
more than twice the recommended amount (2,7 ug Iodine/kg)Fig. 2. Urinary Iodine Content (UIC) in intestinal failure and healthy children. The
horizontal line indicates the median, the box indicates the interquartile range (25th
percentile to 75th percentile), the whiskers represent observations within1.5-times the
inter quartile range and the dot indicate outliers. The dotted line indicates the cut off
value for sufficient status of 100 ug/L.(Table 3b) and the PN recommendation for iodine was met by 79%
of the IF patients. None met the PN recommendation for iron.
Over 70% of the healthy children reached the RI for B1, B2, B6,
B12, vitamin E, vitamin C, copper, magnesium and zinc, and more
than 50% the RI for niacin, vitamin A and selenium. Only 28%
reached the RI for iodine and iron, however median dietary intake




Themedian urine iodine concentrationwas under theWHO cut-
off value for deficiency in the IF group (89 umol/L) but not in the
healthy children (133 umol/L) (Fig. 2).
Frequency of sufficiency iodine status, urinary iodine content
(UIC), iodine intake and percentage of iodine recommendation
reached according to sufficiency status in the two groups is
described in Table 4. Iodine deficiency was frequent in all children,
and not significantly different between the IF group and the
healthy children (53 vs 40% respectively). When correcting for
urine creatinine (Est24hrUIC), the frequency of iodine deficiency
rose to 67% in both groups.
There were significant positive correlations between iodine
status (UIC) and percentage of RI met for iodine in both groups (IF;
r ¼ 0.62, p ¼ 0.01, Healthy; r ¼ 0.35, p ¼ 0.01). In the IF group there
was a significant positive correlation between UIC and the per-
centage of iodine intake from oral diet and enteral nutrition sup-
port (r ¼ 0.57, p ¼ 0.03), as well as a significantly negative
correlation between the percentage of total iodine provision
covered by PN and UIC (r ¼ -0.52, p ¼ 0.03).
When looking at the iodine provision in PN, there was no cor-
relation between meeting the ESPGHAN guidelines for iodine and
UIC. As illustrated in Fig. 3 as many as 6 out of 12 of the patients
who met the daily recommended iodine dose in PN, had insuffi-
cient iodine status.
3.2.2. Iron
The IF group had significantly lower iron intake (Table 3b) and
significantly lower haemoglobin level (Table 5) than the healthy
group. There were significant differences between the groups in
Fig. 3. Urinary Iodine Content (UIC) in relation to Iodine per kg in Parenteral
Nutrition (PN) in the IF group (n ¼ 15). The dotted line indicates the WHO cut-off for
insufficient iodine status (UIC <100 ug/L). The stippled line indicates the ESPGHAN
recommendation for iodine provision in PN (1 ug/kg).
Table 4
Prevalence of iodine sufficient and insufficient status (WHO cut off), iodine status, provision of iodine and prevalence of reaching recommendations from diet/enteral nutrition
(RI) and parenteral nutrition in Intestinal Failure patients and Healthy children.
UIC Intestinal failure n ¼ 15 % reaching RI for
iodine (diet and EN)
% reaching PN
rec for Iodine
Healthy n ¼ 50 % reaching
RI for Iodine
% UIC ug/L Total Iodine
provision ug
% UIC ug/L Iodine
provision ug
Insufficient status <100 53% 58 ug/L 96 ug 0% 75% 40% 69 ug/L 75 ug 15%
Normal 100 47% 157 ug/L 150 ug 14% 86% 60% 178 ug/L 121 ug 40%
UIC ¼ urinary Iodine content, EN ¼ enteral nutrition support, RI ¼ recommended intake enterally (diet and EN), PN rec ¼ recommended PN provision, ESPGHAN guidelines,
Total Iodine provision ¼ Iodine from diet/EN and parenteral nutrition, WHO cut-off values(31).
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saturation and transferrin receptor. Except for transferrin receptor
and serum iron, all values were within the normal range.
A significantly higher prevalence of anaemia was found in the IF
group, where 40% of the children were classified as mildly to
moderately anaemic according to theWHO's classification (Fig. 4), in
comparison to 10% among the healthy children. The IF group
received 33% of their iron from PN, in which the median iron pro-
vision in PN was 26 ug/kg which is only half of the PN recommen-
dation. Three patients did not receive any iron in their PN. There
were no correlations between iron provision from diet, enteral
nutrition support or parenteral nutrition and any of the iron pa-
rameters in blood.
Among the IF group, anaemia was significantly associated with
the age of initiation of HPN. The median age of commencing HPN
was one year among anaemic children compared to 5 years among
those without anaemia (p ¼ 0.04). In addition, there wereTable 5
Haematology in Intestinal Failure patients and healthy children, medians (min/max) and
Haematology Value Intestinal Failure (n ¼ 19) Healthy (n ¼ 49)
Haemoglobin g/dl 11,6 (9,9e13,5) 12,4 (10,8e14,1)
MCV fL 85 (79e88) 82 (74e93)
MCH Pg 28 (26e32) 28 (25e31)
TIBC umol/L 65 (43e105) 68 (43e80)
Iron umol/L 9 (4e25) 14 (3e26)
Ferritin ug/L 59 (13e378) 37 (16e111)
Transferrin g/L 2,7 (1,7e4,2) 2,7 (1,7e3,2)
Transferrin-saturation 0,12 (0,08e0,34) 0,21 (0,05e0,41)
Transferrin-receptor mg/L 4,0 (2,3e7,0) 3,2 (2,3e5,4)
C-reactive protein mg/L 0,5 (0,5e46,5) 0,5 (0,5e34)
IF¼Intestinal Failure.
a Age dependent, MCV - mean corpuscular volume, MCH - mean corpuscular haemogsignificant association between anaemia and the duration of HPN
treatment, 9.5 vs. 3.1 years in those with and without anaemia,
respectively (p ¼ 0.01).
3.2.3. Other micronutrients
The IF group had significantly higher B12 levels than the healthy
group, and elevated levels were found in 78% of the patients
(Table 6). Only one IF patient (6%) had lower vitamin A than the
reference. We found no vitamin E deficiency, in terms of either
tocopherol in the blood or for cholesterol and triglyceride corrected
vitamin E. Elevated vitamin E was frequent (70%). Low magnesium
was found in two patients and low zinc in one. None had selenium
deficiency.
3.2.4. Other blood biomarkers
Around 30% of the IF group had one or more elevated liver
function test (result not shown). None were found to have elevated
lipids or triglycerides. As for thyroid status, low FT4 was found in
two IF patients, and high FT4 in two, but none had elevated TSH.
Albuminwas normal in all IF patients. Low carnitine (free and total)
was found in 19% of the IF patients.
4. Discussion
In this cross-sectional study, lower UIC and a significantly higher
prevalence of anaemia was found in paediatric IF patients on HPN
than healthy children. We found adequate serum levels of most
other micronutrients despite of lower than recommended enteral
intake and/or parenteral provision of some nutrients (Se, Vit E and
Mg). Low serum levels of vitamin A was found in one, low mag-
nesium in two and low zinc in one patients. IF patients received a
median of 76% of their estimated energy requirements (EER) from
PN. PN covered 63% of the total provision of iodine, whereas iron
was mostly provided by oral diet and enteral nutrition support.
In contrast to other studies [7,15,21e23] on micronutrients in IF
patients, we found adequate levels of vitamins and most tracefrequency of low and elevated levels.
Reference p-value Low/elevated levels (%)
IF Healthy
11.0e13a 0.01 42% low 12% low
70/76/78e87/95/98a 0.02 2% low
23/25e31/33a 0.40
0.90
5-20/25a 0.003 10% low, 6% elevated 2% low, 4% elevated
<12/<15a 0.09 6% low 16% elevated
1,9e3,3 0.95
0,05/0,06e0,39/0,58a 0.005
1,9/2,2e4,4/5,0a 0.007 20% elevated 4% elevated
<4,0 0.35 11% elevated 4% elevated
lobin, TIBC e total iron binding capacity.
Fig. 4. Prevalence of anaemia (mild and moderate) in Intestinal Failure Patients
and Healthy Children. *p ¼ 0.016.
R.A. Thomassen et al. / Clinical Nutrition 39 (2020) 3452e34603458elements. Previous studies have been retrospective in design
without information on enteral and/or parenteral nutrition. Many
have focused on patients in transition between parenteral nutrition
and full enteral nutrition, a period where the patients could be at
risk due to malabsorption of enteral nutrition and insufficient
enteral micronutrient supplementation [7,15,21]. In some cases PN
was not supplemented with all vitamins or trace elements [17,22]
The patients in our study were all on stable regimens of parenteral
nutrition. In addition, they all received a parenteral water-soluble
multivitamin solution, at a median of one standard dose which
led to a significantly higher provision of these vitamins than in
healthy children on normal diet. Moreover, the IF group was pro-
vided with a fat-soluble vitamin solution and a multi trace element
solution. This could also explain the lack of nutritional deficiencies
found in our study.
The IF group received a median of 2.7 ug of iodine per kg in
their PN, which is more than twice the amount recommended by
ESPGHAN [28]. Despite this there was a high prevalence of
insufficient iodine status, defined as UIC <100 ug/L with more
than half of the IF group below the cut-off value. This was true
even when correcting for hydration status with urine creatinine
(Est24hrUIC). In comparison 40% of the healthy children had UIC
values < 100 ug/L and the prevalence rose to 67% when correcting
for hydration status (Est24hrUIC). There are few studies on iodine
status in patients treated with HPN. Iodine is difficult to study and
there has previously been a widespread notion that the needs forTable 6
Median blood values (min/max) of micronutrient status in Intestinal Failure patients and
(value) Intestinal failure n ¼ 19 Healthy n ¼ 49
Vitamins
B12 (pmol/L) 717 (432e1912) 436 (162e955)
Folate (mmol/L) 38 (15e46) 20 (5e46)
Vitamin A (umol/L) 1,7 (1,1e4,7)
6% elevated
Vitamin E (umol/L) 28 (14e40)
Corr Vit Ea (umol/mmol) 7,5 (4,5e9,8)
Minerals/Trace elements
Magnesium (mmol/L) 0,81 (0,66e1,05)
Zinc (umol/L) 17,5 (9e30)
Selenium (umol/l) 1,3 (0,9e1,5)
a Corrected vitamin E: Vitamin E/(triglycerides þ Cholesterol). IF - Intestinal Failure.iodine in patients receiving PN were covered by the use of iodine
containing antiseptics [33]. However, these products are no longer
used on a regular basis. In Europe PN is commonly supplemented
with iodine by a multi trace element solution. In contrast, trace
element supplementation of PN in the United States (US) is often
done by individually adding the different trace elements and
iodine is not routinely included in this supplementation [18].
There have been a few case reports of hypothyroidism due to
iodine deficiency in children on HPN in the US [34e36] and a
recent study found high prevalence of iodine deficiency in pae-
diatric IF patients provided HPN without iodine, with 33% devel-
oping hypothyroidism [18]. However, these studies are on
children who were not provided with intravenous iodine and
cannot be used to evaluate the current ESPGHAN recommenda-
tion for iodine in PN.
There is a large discrepancy between the amount of iodine
recommended in the diet (90e150 ug in children 2e18 years old)
and in parenteral nutrition (1 ug/kg/day) [33]. The newly published
ESPGHAN guidelines did not increase the recommendation even if
the authors recognized that the risk of iodine deficiency is high.
Instead, ESPGHAN suggests that patients on long-term PN should
be regularly monitored for iodine status bymeasuring their thyroid
hormone concentration (TSH) [28]. We found little sign of distur-
bances in thyroid function in our group of IF patients. All subjects
had TSH within the normal range even if four IF patients had FT4
values that were slightly outside the reference range. However,
even if TSHmay be slightly raised by iodine deficiency, values often
remain within the normal range and are therefore a rather insen-
sitive indicator of iodine nutrition in children and adults. This is
true for FT4 as well [33]. Moreover, thyroid dysfunction is a late
consequence of iodine deficiency. Cognitive function and behaviour
may be negatively affected much earlier compared to thyroid hor-
mone production [37]. This was, however, not investigated in the
present study.
Considering that 90% of iodine in the diet is absorbed in the
intestine it is illogical for the parenteral guideline to be so much
lower than enteral requirements. Especially for small children with
low weights the discrepancy between enteral and parenteral
recommendation is large as the PN guideline is based on weight.
Premature low weight children were found to be at high risk of
iodine deficiency in one study [38]. Even though our group of IF
patients were provided more than twice the ESPGHAN iodine
recommendation they still showed signs of insufficient iodine
status. The same was found in an adult group of IF patients treated
with HPN and there is a need for more studies to establish iodine
requirements in HPN [12].healthy children and frequency of low and elevated levels.
Reference p-value Frequency of low/elevated levels (%)
IF Healthy
>150 <0.001 78% elevated 2% deficiency
8% elevated








R.A. Thomassen et al. / Clinical Nutrition 39 (2020) 3452e3460 3459The prevalence of low UIC was higher in the IF group than
among the reference group. IF patients were provided most of their
iodine from PN (63% of total provision). Nevertheless, UIC had a
significantly positive correlation with the amount of iodine from
the diet, and enteral provision of iodine seems important in
ensuring sufficient iodine in children treated with HPN.
It seems warranted to recommend that clinicians evaluate the
iodine provision from diet and enteral nutrition support in their IF
patients on HPN and look more to the recommendations of enteral
nutrition to avoid iodine deficiency in this group. In cases of low
enteral tolerance iodine can be added to PN as an individual sup-
plement [33].
Diet and/or enteral nutritional support were the main
contributor of iron for the majority of IF patients in this study.
Nevertheless, they met less than 50% of the recommended intake
of iron, while the healthy group met more than 80%. Iron is difficult
to provide in parenteral nutrition due to concerns about compat-
ibilities [20]. Moreover, enteral supplementation may not be
effective in IF patients due to malabsorption, the use of antacid
drugs and the risk of GI complications. In this study the IF group
had a significantly higher prevalence of mild and moderate
anaemia than the healthy children. IF patients with anaemia ten-
ded to have been treated with HPN for significantly longer and
commenced HPN at a younger age than those without. However,
most iron parameters were within the normal range and none of
the participants were diagnosedwith iron deficiency. Other studies
have found high rates of both anaemia and iron deficiency anaemia
in children and adult IF patients on HPN [19,20,23]. Diagnosing
iron deficiency and iron deficiency anaemia can be challenging
because depletion occurs in stages and may be asymptomatic.
Defining iron deficiency in IF patients is particularly difficult as
many have low-grade inflammation even if C-reactive protein
levels are normal [39]. Therefore, it is important to consider the
complete medical picture. Haemoglobin, ferritin, total iron binding
capacity and transferrin saturation should be monitored regularly
to track changes. Some authors have recommended measuring
transferrin receptor to establish iron deficiency because this
parameter is not affected as much by inflammation [13]. However,
we found no associations between transferrin receptor, anaemia,
haemoglobin or ferritin in our study. Iron deficiency anaemia has
detrimental effects on a child's development and can affect im-
mune function, physical work capacity, and mental, motor, and
emotional development [40e42]. Therefore, monitoring iron sta-
tus is important, and regular iron intravenous supplementation
should be considered in individuals who are at risk, such as those
with minimal enteral diet, patients with chronic inflammation and
young girls after menarche.
A strength of this study is that all IF patients on HPN at our
center at the time of investigation were included. In addition,
detailed data on provision of nutrients from diet, enteral nutri-
tion support and parenteral nutrition was obtained at the same
time as measurements of micronutrient status in blood and
urine.
However, some limitations should be noted. The sample size of
IF patients on HPN was small, allowing for type 2 errors. The
reference group was recruited by advertisement in social media
and participants could therefore be healthier than the general
population. However, the dietary intake of the reference group was
comparable to the intake of Norwegian 9 year olds in the last na-
tional dietary investigation study in Norway [43]. Another possible
limitation is the validity of urine iodine as a marker of iodine
deficiency among children on parenteral nutrition. This study raises
questions regarding iron and iodine status of IF patients on home-
parenteral nutrition and further studies are needed on measure-
ments to avoid deficiencies of these nutrients.5. Conclusion
In this cross-sectional study of paediatric IF patients an
adequate nutritional status and nutrient provision were found for
most micronutrients. The exceptions were iodine and iron.
Compared to healthy children, IF patients had poorer iodine and
iron status. Anaemia was prevalent, and iron provision was low.
Iodine status was associated with enteral provision and when
providing twice the ESPGHAN recommendation, insufficient iodine
status still occurred in the IF population.Funding
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